Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomised, open, parallel-group, multicentre, 26 weeks study https://kusajili.com:443/Trial/hugH9XHW_kSnwDKIvgQwAw%24a-comparison-of-the-efficacy-of-symbicort-single-inhaler-therapy-symbicort-turbuhaler-16045-microg-one-inhalation-twice-a-day-p
I have read and accept the terms of use of the site and the Privacy Policy
Send your message